MYC and cancer: In agreement with our initial assessment, GSEA revealed an increase in immune activation pathways in the LTF-high patients, including Allograft Rejection and Complement Signaling, and a reduction in cancer-related pathways, including Mitotic Spindle and Myc Targets (Figure 5, B and C).